Literature DB >> 15887162

Liver transplantation for hepatocellular carcinoma.

Alex S Befeler1, Paul H Hayashi, Adrian M Di Bisceglie.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15887162     DOI： 10.1053/j.gastro.2005.03.033

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  35 in total

1.  Up-regulation of microRNA-155 promotes cancer cell invasion and predicts poor survival of hepatocellular carcinoma following liver transplantation.

Authors:  Zhong-Bo Han; Hong-Yuan Chen; Jun-Wei Fan; Jun-Yi Wu; Hua-Mei Tang; Zhi-Hai Peng
Journal:  J Cancer Res Clin Oncol       Date:  2011-11-10       Impact factor: 4.553

2.  Comparison of Milan and UCSF criteria for liver transplantation to treat hepatocellular carcinoma.

Authors:  Tarkan Unek; Sedat Karademir; Naciye Cigdem Arslan; Tufan Egeli; Gulsen Atasoy; Ozgul Sagol; Funda Obuz; Mesut Akarsu; Ibrahim Astarcioglu
Journal:  World J Gastroenterol       Date:  2011-10-07       Impact factor: 5.742

3.  Effect of antiviral treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis B.

Authors:  Konstantinos Tziomalos
Journal:  World J Hepatol       Date:  2010-03-27

4.  PI-103 and sorafenib inhibit hepatocellular carcinoma cell proliferation by blocking Ras/Raf/MAPK and PI3K/AKT/mTOR pathways.

Authors:  Roberto Gedaly; Paul Angulo; Jonathan Hundley; Michael F Daily; Changguo Chen; Alvaro Koch; B Mark Evers
Journal:  Anticancer Res       Date:  2010-12       Impact factor: 2.480

5.  Identification of recurrence-related microRNAs in hepatocellular carcinoma following liver transplantation.

Authors:  Zhong-Bo Han; Lin Zhong; Mu-Jian Teng; Jun-Wei Fan; Hua-Mei Tang; Jun-Yi Wu; Hong-Yuan Chen; Zhao-Wen Wang; Guo-Qiang Qiu; Zhi-Hai Peng
Journal:  Mol Oncol       Date:  2012-04-17       Impact factor: 6.603

Review 6.  The Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The Puri Recommendations.

Authors:  Ashish Kumar; Subrat K Acharya; Shivaram P Singh; Vivek A Saraswat; Anil Arora; Ajay Duseja; Mahesh K Goenka; Deepali Jain; Premashish Kar; Manoj Kumar; Vinay Kumaran; Kunisshery M Mohandas; Dipanjan Panda; Shashi B Paul; Jeyamani Ramachandran; Hariharan Ramesh; Padaki N Rao; Samir R Shah; Hanish Sharma; Ragesh B Thandassery
Journal:  J Clin Exp Hepatol       Date:  2014-05-22

7.  Indications for living donor liver transplantation in patients with hepatocellular carcinoma.

Authors:  Yasuhiko Sugawara; Yukihiro Inomata
Journal:  Hepatobiliary Surg Nutr       Date:  2016-10       Impact factor: 7.293

8.  Sorafenib treatment is save and may affect survival of recurrent hepatocellular carcinoma after liver transplantation.

Authors:  Jan Pfeiffenberger; Ronald Koschny; Katrin Hoffmann; Arianeb Mehrabi; Anne Schmitz; Boris Radeleff; Wolfgang Stremmel; Peter Schemmer; Tom M Ganten
Journal:  Langenbecks Arch Surg       Date:  2013-10-04       Impact factor: 3.445

9.  Liver transplantation.

Authors:  Deok-Bog Moon; Sung-Gyu Lee
Journal:  Gut Liver       Date:  2009-09-30       Impact factor: 4.519

10.  Is Portal Vein Embolization Followed by Hepatectomy for Hepatocellular Carcinoma Justified in Patients with Impaired Liver Function?

Authors:  Katsunori Imai; Yo-Ichi Yamashita; Yosuke Nakao; Takashi Matsumoto; Shotaro Kinoshita; Toshihiko Yusa; Yuki Kitano; Takayoshi Kaida; Hiromitsu Hayashi; Hideo Baba
Journal:  Ann Surg Oncol       Date:  2020-08-01       Impact factor: 5.344
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.